Biotech Stocks Are on a Tear. They Could Keep Climbing
An ETF that tracks the biotech sector closed above $100 for the first time in just over two years on Tuesday.
Source: marketwatch.com
Stay updated with breaking news from Tim Opler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An ETF that tracks the biotech sector closed above $100 for the first time in just over two years on Tuesday.
Bets on interest-rate cuts plus a surge in pharma deals mean the worst is likely over for the biotech sector
As investors begin to see light at the end of the tunnel, their risk appetite, which had vanished amid recession risks and volatility, is coming back, creating chances of major investments in high-risk...
44pc users experience nausea; Obesity market could be worth $100bn by 2030